12/06/2026
๐ ๐๐ฉ๐๐จ๐ฆ๐ข๐ง๐ ๐๐๐๐ข๐ง๐๐ซ: ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ข๐ง๐ ๐๐๐ญ๐ฎ๐ซ๐ง ๐จ๐ง ๐๐ง๐ฏ๐๐ฌ๐ญ๐ฆ๐๐ง๐ญ (๐๐๐) ๐ข๐ง ๐๐ข๐จ๐๐ช๐ฎ๐ข๐ฏ๐๐ฅ๐๐ง๐๐ ๐๐ญ๐ฎ๐๐ข๐๐ฌ
Join us for an engaging and expert-led webinar designed to help pharmaceutical professionals unlock greater value from Bioequivalence (BE) studies. This session will highlight practical strategies to optimize study design, improve operational efficiency, navigate regulatory requirements, and maximize overall return on investment in an increasingly competitive market.
๐
Date: ๐๐ ๐๐ฎ๐ง๐ ๐๐๐๐
โฐ Time: ๐๐:๐๐ ๐๐ โ ๐๐:๐๐ ๐๐ (๐๐๐)
๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ
๐น Understanding the major factors that influence ROI in BE studies
๐น Effective study planning and resource optimization strategies
๐น Regulatory considerations that contribute to successful outcomes
๐น Cost-reduction approaches while maintaining quality and compliance
๐น Best practices to enhance study success and accelerate market access
๐
๐๐๐ญ๐ฎ๐ซ๐๐ ๐๐ฉ๐๐๐ค๐๐ซ
Kenneth Ho
B.Pharm (Hons), R.Ph, MMPS, PJK
Senior Manager โ Business Development, Info Kinetics
๐๐จ๐๐๐ซ๐๐ญ๐จ๐ซ
Syeda Hiba Jaffar
Senior Clinical Research Associate
Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS-DUHS) Dow University of Health Sciences (DUHS), Ojha Campus
Register Now: https://lnkd.in/dUB4wTxc